AQR Capital Management’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-33,823
| Closed | -$148K | – | 3293 |
|
|
2025
Q1 | $148K | Buy |
+33,823
| New | +$148K | ﹤0.01% | 2945 |
|
|
2024
Q4 | – | Sell |
-59,970
| Closed | -$421K | – | 2864 |
|
|
2024
Q3 | $421K | Buy |
+59,970
| New | +$421K | ﹤0.01% | 2247 |
|
|
2021
Q1 | – | Sell |
-2,157
| Closed | -$234K | – | 2179 |
|
|
2020
Q4 | $234K | Sell |
2,157
-4,431
| -67% | -$481K | ﹤0.01% | 2042 |
|
|
2020
Q3 | $679K | Sell |
6,588
-2,344
| -26% | -$242K | ﹤0.01% | 1598 |
|
|
2020
Q2 | $1.87M | Sell |
8,932
-8,811
| -50% | -$1.84M | ﹤0.01% | 1181 |
|
|
2020
Q1 | $1.73M | Buy |
17,743
+13,876
| +359% | +$1.36M | ﹤0.01% | 1120 |
|
|
2019
Q4 | $445K | Buy |
3,867
+955
| +33% | +$110K | ﹤0.01% | 1786 |
|
|
2019
Q3 | $159K | Buy |
2,912
+486
| +20% | +$26.5K | ﹤0.01% | 2039 |
|
|
2019
Q2 | $288K | Sell |
2,426
-1,033
| -30% | -$123K | ﹤0.01% | 1887 |
|
|
2019
Q1 | $181K | Sell |
3,459
-4,280
| -55% | -$224K | ﹤0.01% | 2086 |
|
|
2018
Q4 | $244K | Sell |
7,739
-6,169
| -44% | -$195K | ﹤0.01% | 2028 |
|
|
2018
Q3 | $841K | Buy |
13,908
+10,431
| +300% | +$631K | ﹤0.01% | 1767 |
|
|
2018
Q2 | $184K | Buy |
+3,477
| New | +$184K | ﹤0.01% | 2234 |
|
|
2016
Q3 | – | Sell |
-12,395
| Closed | -$392K | – | 2245 |
|
|
2016
Q2 | $392K | Buy |
12,395
+1,922
| +18% | +$60.8K | ﹤0.01% | 1948 |
|
|
2016
Q1 | $541K | Sell |
10,473
-203
| -2% | -$10.5K | ﹤0.01% | 1807 |
|
|
2015
Q4 | $1.02M | Buy |
+10,676
| New | +$1.02M | ﹤0.01% | 1563 |
|